Actively Recruiting
International Registry for Patients With Castleman Disease
Led by University of Pennsylvania · Updated on 2026-03-03
1000
Participants Needed
1
Research Sites
569 weeks
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
E
EUSA Pharma, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.
CONDITIONS
Official Title
International Registry for Patients With Castleman Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Person of any age
- Have a reference pathology report suggesting "Castleman disease" not limited to cutaneous involvement only that can be uploaded
- Be able to provide electronic informed consent, as per local regulations
- Deceased patients may also be enrolled when a reference pathology report suggesting "Castleman disease" can be supplied or when the ART is able to locate and upload such a pathology report.
You will not qualify if you...
- None; this registry has deliberately wide inclusion criteria and no exclusion criteria.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
J
Joshua Brandstadter, MD, PhD, MSc
CONTACT
B
Bridget Austin, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here